UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

NCT07500805 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

CD70-positive Advanced Renal Clear Cell Carcinoma

Interventions

BIOLOGICAL: UCL70805F

Sponsor

UTC Therapeutics Inc.

Collaborators

[object Object]